Get FREE CE for this episode by downloading the CEimpact App (details in the FREE CE section).
The current reality of COVID-19 is reviewed in this episode by Dr. Katelyn Jetelina. Dr. Jetelina is an epidemiologist and author of the wildly popular Newsletter, Your Local Epidemiologist, available via Substack.
We are losing ~400 Americans a day. During the first week of September, we lost 2,299 people. In August 2022 alone, we lost 15,284 Americans to COVID-19. This means COVID-19 remains the third leading cause of death in our repertoire of threats. And it’s largely preventable.
Pharmacists continue to support the frontlines of the COVID-19 Pandemic. This episode shares insights on the current reality as well as what you need to know about bivalent boosters, and vaccinating children.
The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training. Use discount code THANKYOU to save 10%.
00:00 - Introductions
03:38 - Is COVID-19 Still a Thing?
10:55 - The GameChanger: Bivalent Booster
17:15 - The Different Boosters
19:40 - Applying to Practice: Dosing
22:48 - Pediatric Considerations
28:35 - Closing Thoughts
References and Resources
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc
Katelyn Jetelina, MPH, PhD
Publisher, Your Local Epidemiologist
Subscribe to Katelyn's substack - Your Local Epidemiologist to receive a direct line of “translated” public health science to the local, national, and international community.
Redeem your CPE or CME here
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the current state of COVID-19 pandemic the United States
2. Describe the role of a bivalent vaccine for COVID-19
0.05 CEU/0.5 Hr
Initial release date: 10/3/2022